Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma

Leukemia

Volumn 12, Issue 4, 1998, Pages 593-600

  Donovan, K A ^a   Lacy, M Q ^a   Kline, M P ^a   Ahmann, G J ^a   Heimbach, J K ^a   Kyle, R A ^a   Lust, J A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Interleukin 1 ; Interleukin 6; MGUS; Myeloma; RT PCR

Indexed keywords

CD38 ANTIGEN; CD45 ANTIGEN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CELL POPULATION; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN CELL; IN SITU HYBRIDIZATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031957405     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400873     Document Type: Article

References (14)

1. Silverberg E, Boring CC, Squires TS. Cancer Statistics 1996. CA-A Cancer J Clin 1996; 46: 5-27.
2. Kyle RA, Lust JA. Monoclonal gammopathies of undetermined significance. Sem Hematol 1989; 26: 176-200.
3. Kyle RA. 'Benign' monoclonal gammopathy - after 20 to 35 years of follow-up. Mayo Clin Proc 1993; 68: 26-36.
4. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H. Kuramoto A, Kishimoto A. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83-85.
5. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 1993; 81: 3357-3364.
6. Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdorp PM, Di Gugielemo R. Production of interleukin-1 by bone marrow myeloma cells. Blood 1989; 74: 380-387.
7. Carter A, Merchav S, Silvian-Draxler I, Tatarsky I. The role of interleukin-1 and tumour necrosis factor-α in human multiple myeloma. Br J Haematol 1990; 74: 424-431.
8. Kyle RA, Greipp PR. Smoldering multiple myeloma. New Engl J Med 1980; 302: 1347-1349.
9. Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA, O'Fallon WM, Kyle RA. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. Mayo Clin Proc 1987; 62: 969-977.
10. 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 1993; 81: 3382-3387.
11. Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA, Maihle NJ. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992; 4: 96-100.
12. Lust JA, Jelinek DF, Donovan KA, Frederick LA, Huntley BK, Braaten JK, Maihle NJ. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIsIL-6R). Curr Top Microbiol Immunol 1994; 194: 199-206.
13. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517-526.
14. Portier M, Rajzbaum G, Zhang XG, Attal M, Rusalen C, Wijdenes J, Mannoni P, Maraninchi D, Piechadzyk M, Bataille R, Klein B. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma. Eur J Immunol 1991; 21: 1759-1762.